Search

Your search keyword '"Turtle, Cameron J."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Turtle, Cameron J." Remove constraint Author: "Turtle, Cameron J." Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
40 results on '"Turtle, Cameron J."'

Search Results

1. Figure S6 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

2. Figure S2 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

3. Data from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

4. Figure S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

5. Figure S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

6. Figure S7 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

7. Figure S4 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

8. Figure S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

9. Supplementary text_tables_figurelegends from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

10. Data from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

11. Figure S5 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

12. Figure S3 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

13. Figure S7 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

14. Figure S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

15. Data from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

16. Figure S2 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

17. Figure S4 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

18. Figure S6 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

19. Table S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

20. Table S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

21. Table S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

22. Figure S3 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

23. Figure S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

24. Data from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

25. Supplementary text_tables_figurelegends from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

26. Table S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

27. Table S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

28. Figure S4 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

29. Figure S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

30. Figure S5 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

31. Figure S1 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

32. Figure S5 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

33. Figure S1 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

34. Figure S4 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

35. Table S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

36. Figure S5 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

37. Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia

38. Abstract CT131: A phase I study of adoptive immunotherapy for advanced ROR1+ malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)

39. Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

40. Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

Catalog

Books, media, physical & digital resources